| Net loss | -4.85M |
| Depreciation, depletion and amortization | 101.79M |
| Accretion of asset retirement obligation and receivable | |
| Amortization of intangible assets and liabilities, net | |
| Non-cash tax benefits | |
| Share-based compensation | 5.93M |
| Loss (gain) on sales of assets | |
| Non-cash interest expense | |
| Amortization of deferred financing costs | 8.32M |
| Loss on extinguishment of debt | |
| Gain on sales of investment securities | |
| Loss (gain) on derivative instruments | 2.16M |
| Receivables, net | -238K |
| Inventories | 9.46M |
| Excess of pneumoconiosis benefit obligation over trust assets | |
| Accounts payable and accrued expenses | -2.33M |
| Deferred revenue | 4.31M |
| Accrual for workers' compensation | |
| Asset retirement obligation | |
| Accrual for postretirement medical benefits | |
| Pension and SERP obligations | |
| Other assets and liabilities | 7.38M |
| Net cash provided by in operating activities | 84.24M |
| Additions to property, plant and equipment | -30.62M |
| Change in restricted investments and bond collateral and reclamation deposits | |
| Net proceeds from sales of assets | |
| Proceeds from sale of restricted investments | 6.18M |
| Receivable from customer for property and equipment purchases | |
| Net cash used in investing activities | -147.36M |
| Change in book overdrafts | |
| Borrowings from long-term debt, net of debt discount | 122.25M |
| Repayments of long-term debt | -43.88M |
| Borrowings on revolving lines of credit | 313.9M |
| Repayments of revolving lines of credit | -315.9M |
| Debt issuance and other refinancing costs | -7.25M |
| Preferred dividends paid | |
| Exercise of stock options | |
| Net cash provided by (used in) financing activities | 68.33M |
| Net increase in cash and cash equivalents | 5.98M |
| Cash and cash equivalents, beginning of period | 22.94M |
| Cash and cash equivalents, end of period | 28.91M |
| Capital leases | |